Eldrin F Lewis Selected Research

Darbepoetin alfa (Aranesp)

1/2021	Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
1/2021	Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
1/2021	Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics.
1/2019	Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
1/2019	Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
10/2017	ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
1/2016	Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
11/2015	Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
9/2015	Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
8/2015	Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eldrin F Lewis Research Topics

Disease

77	Heart Failure 01/2022 - 03/2004
21	Myocardial Infarction 10/2022 - 07/2004
20	Chronic Renal Insufficiency 01/2021 - 07/2009
18	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2009
16	Stroke (Strokes) 01/2021 - 05/2008
16	Anemia 01/2021 - 07/2009
12	Acute Coronary Syndrome 01/2022 - 07/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2009
7	Heart Arrest (Cardiac Arrest) 11/2021 - 04/2014
7	Hyperkalemia 01/2019 - 03/2013
6	Diabetes Mellitus 01/2019 - 12/2011
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2009
5	Death (Near-Death Experience) 11/2016 - 05/2008
4	Obstructive Sleep Apnea 01/2022 - 06/2014
4	Hypoxia (Hypoxemia) 01/2021 - 06/2014
4	Cardiomyopathies (Cardiomyopathy) 10/2019 - 03/2015
4	Hypokalemia 01/2019 - 04/2014
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 11/2009
4	Atrial Fibrillation 01/2018 - 05/2008
4	Apnea 07/2017 - 02/2014
3	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 06/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2020 - 03/2015
3	Edema (Dropsy) 10/2019 - 07/2012
3	Renal Insufficiency (Renal Failure) 01/2014 - 02/2006
3	Proteinuria 12/2011 - 07/2009
3	Cardio-Renal Syndrome 10/2011 - 07/2010
3	Fatigue 04/2011 - 11/2009
3	Left Ventricular Dysfunction 07/2009 - 06/2004
3	Hemorrhage 05/2008 - 07/2004
2	Kidney Diseases (Kidney Disease) 01/2019 - 04/2011
2	Coronary Disease (Coronary Heart Disease) 07/2017 - 07/2014
2	Neoplasms (Cancer) 03/2016 - 04/2011
2	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 05/2014
2	Hypotension (Low Blood Pressure) 10/2013 - 03/2013
2	Atherosclerosis 03/2013 - 05/2008
2	Infarction (Infarctions) 06/2010 - 05/2008
1	ST Elevation Myocardial Infarction 01/2021

Drug/Important Bio-Agent (IBA)

26	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 12/2011
18	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 12/2011
17	Darbepoetin alfa (Aranesp)FDA Link 01/2021 - 07/2009
12	Hemoglobins (Hemoglobin)IBA 01/2021 - 07/2009
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 06/2004
8	Natriuretic PeptidesIBA 01/2022 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 08/2020 - 10/2011
8	CreatinineIBA 11/2018 - 02/2006
6	HematinicsIBA 01/2021 - 07/2009
5	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 08/2017
5	Valsartan (Vals)FDA Link 11/2021 - 05/2008
5	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2020 - 10/2011
5	aliskiren FDA Link 01/2018 - 01/2011
4	lixisenatideIBA 01/2022 - 05/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 09/2004
4	Tirofiban (Aggrastat)FDA Link 11/2009 - 07/2004
3	Erythropoietin FDA Link 01/2021 - 01/2021
3	Prolyl-Hydroxylase InhibitorsIBA 01/2021 - 01/2021
3	vadadustatIBA 01/2021 - 01/2021
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2017
3	DiureticsIBA 05/2018 - 06/2008
3	Oxygen (Dioxygen)IBA 07/2017 - 02/2014
3	Edetic Acid (EDTA)FDA Link 07/2014 - 03/2013
3	Simvastatin (Zocor)FDA LinkGeneric 11/2009 - 09/2004
2	Ramipril (Altace)FDA LinkGeneric 01/2022 - 11/2021
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2021 - 08/2017
2	Neprilysin (Neutral Endopeptidase)IBA 11/2021 - 08/2017
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	candesartanIBA 01/2020 - 01/2007
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2010
2	Insulin (Novolin)FDA Link 01/2019 - 01/2018
2	PotassiumIBA 05/2018 - 01/2015
2	Angiotensin Receptor AntagonistsIBA 05/2018 - 07/2009
2	ReninIBA 01/2018 - 03/2016
2	Renin InhibitorsIBA 01/2018 - 10/2013
2	Enalapril FDA LinkGeneric 01/2018 - 08/2017
2	SodiumIBA 12/2017 - 02/2006
2	AldosteroneIBA 03/2016 - 12/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2015 - 05/2008
2	Troponin T (Troponin T1)IBA 11/2011 - 10/2011
2	Captopril (Capoten)FDA LinkGeneric 07/2009 - 05/2008
2	Heparin (Liquaemin)FDA LinkGeneric 10/2004 - 07/2004
2	Enoxaparin (Lovenox)FDA LinkGeneric 10/2004 - 07/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2004 - 07/2004
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2022
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 10/2022
1	MineralsIBA 10/2022
1	SolutionsIBA 10/2022
1	sacubitrilIBA 11/2021

Therapy/Procedure

44	Therapeutics 01/2022 - 09/2004
4	Chelation Therapy (Therapy, Chelation) 11/2020 - 03/2013
3	Continuous Positive Airway Pressure 01/2022 - 01/2017
3	Patient Readmission 01/2021 - 05/2008
3	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2017 - 11/2011
3	Palliative Care (Palliative Therapy) 06/2014 - 07/2010
3	Heart Transplantation (Grafting, Heart) 02/2011 - 03/2004
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2018 - 02/2010
2	Heart-Assist Devices 06/2017 - 02/2011
2	Terminal Care (Care, Terminal) 06/2014 - 02/2011
2	Long-Term Care 05/2011 - 07/2010
2	Investigational Therapies (Experimental Therapy) 05/2011 - 07/2010
2	Cardiac Resynchronization Therapy 02/2011 - 10/2006
1	Polypharmacy 11/2021